Cryoablation has been found to be a safe and effective ablative therapy that offers a high rate of local tumor control in breast cancer liver metastases, according to a study published in the March 2014 issue of Clinical Radiology.

DioGenix announced Jan. 27 that preliminary research validates the company’s genetic sequencing assay, MSPrecise. The screening tool would identify people with multiple sclerosis (MS) in the very earliest stages of disease when symptoms are still subtle. 

OctreoPharm Sciences based in Berlin announced Jan. 29 that OPS202, an imaging agent for the detection of gastro-entero-pancreatic neuroendocrine tumors, received orphan drug designation from the European Medicines Agency.

Patients with breast cancer who undergo mammography screening between the ages of 40 and 49 benefit from receiving a diagnosis at an earlier stage, are less likely to require chemotherapy and its associated morbidities, and may benefit from chemoprevention, according to a study published in the February issue of the American Journal of Roentgenology.

Pain is unavoidable. It alerts sufferers to very real threats via injury and disease and is invaluable for that reason, but it is also vague and imprecise and sometimes just mysterious, especially in cases of chronic pain disorders. Stanford scientists sought to develop a biomarker that could visualize the molecular changes that signal pain generation and potentially use it to gauge wound healing and to assist in drug trials. 

The U.S. Preventive Services Task Force (USPSTF) recommendation for lung cancer screening finalized last year has been slow to gain the awareness and notoriety of other cancer screening recommendations, according to a panel discussion on non-small cell lung cancer conducted by The American Journal of Manage Care (AJMC).

Presurgical scanning for metastatic non-small cell lung cancer appears to lower incidence of unnecessary surgeries, according to an analysis published Jan. 21 in the Journal of Nuclear Medicine.

The combination of higher estrogen levels and a diabetes diagnosis is associated with 14 times the risk of developing dementia for older women, according to a study published Jan. 29 in Neurology.